{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:12:29Z","timestamp":1740028349681,"version":"3.37.3"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1124\/mol.114.094375","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T07:48:38Z","timestamp":1417506518000},"page":"286-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reversing Translational Suppression and Induction of Toxicity in Pancreatic Cancer Cells Using a Chemoprevention Gene Therapy Approach"],"prefix":"10.1016","volume":"87","author":[{"given":"Siddik","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget A.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuening","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swadesh K.","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luni","family":"Emdad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devanand","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.114.094375_bib1","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/jcp.22947","article-title":"Enhanced delivery of mda-7\/IL-24 using a serotype chimeric adenovirus (Ad.5\/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells","volume":"227","author":"Azab","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1124\/mol.114.094375_bib2","first-page":"34","article-title":"Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5\/3-CTV)","volume":"229","author":"Azab","year":"2014","journal-title":"J Cell Physiol"},{"key":"10.1124\/mol.114.094375_bib3","doi-asserted-by":"crossref","first-page":"32596","DOI":"10.1074\/jbc.274.46.32596","article-title":"Hydrogen peroxide activates p70(S6k) signaling pathway","volume":"274","author":"Bae","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.094375_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/JVI.72.1.415-419.1998","article-title":"The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses","volume":"72","author":"Bergelson","year":"1998","journal-title":"J Virol"},{"key":"10.1124\/mol.114.094375_bib5","first-page":"138","article-title":"Inhibition of farnesyl protein transferase and P21ras membrane association by d-limonene in human pancreas tumor cells in vitro","volume":"14","author":"Chen","year":"1999","journal-title":"Chinese Med Sci J"},{"key":"10.1124\/mol.114.094375_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymthe.2004.09.019","article-title":"Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study","volume":"11","author":"Cunningham","year":"2005","journal-title":"Mol Ther"},{"key":"10.1124\/mol.114.094375_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cytogfr.2010.08.004","article-title":"mda-7\/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity","volume":"21","author":"Dash","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1124\/mol.114.094375_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/cgt.2009.91","article-title":"Enhanced delivery of mda-7\/IL-24 using a serotype chimeric adenovirus (Ad.5\/3) improves therapeutic efficacy in low CAR prostate cancer cells","volume":"17","author":"Dash","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"10.1124\/mol.114.094375_bib9","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1073\/pnas.1100769108","article-title":"Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7\/IL-24-mediated toxicity","volume":"108","author":"Dash","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.114.094375_bib10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/0008-5472.CAN-13-1062","article-title":"Novel mechanism of MDA-7\/IL-24 cancer-specific apoptosis through SARI induction","volume":"74","author":"Dash","year":"2014","journal-title":"Cancer Res"},{"key":"10.1124\/mol.114.094375_bib11","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1517\/14712598.8.10.1633","article-title":"Ad-MDA-7; INGN 241: a review of preclinical and clinical experience","volume":"8","author":"Eager","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"10.1124\/mol.114.094375_bib12","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4161\/cbt.10.12.13497","article-title":"Enhancing mda-7\/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5\/3 gene delivery","volume":"10","author":"Eulitt","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"10.1124\/mol.114.094375_bib13","doi-asserted-by":"crossref","first-page":"10128","DOI":"10.1158\/0008-5472.CAN-05-3127","article-title":"Is mda-7\/IL-24 a \u201cmagic bullet\u201d for cancer?","volume":"65","author":"Fisher","year":"2005","journal-title":"Cancer Res"},{"issue":"4, Suppl 1","key":"10.1124\/mol.114.094375_bib14","first-page":"S23","article-title":"mda-7\/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic","volume":"2","author":"Fisher","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"10.1124\/mol.114.094375_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.taap.2006.11.021","article-title":"Melanoma differentiation associated gene-7\/interleukin-24 (mda-7\/IL-24): novel gene therapeutic for metastatic melanoma","volume":"224","author":"Fisher","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/mol.114.094375_bib16","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/mt.2010.29","article-title":"Inhibition of multiple protective signaling pathways and Ad.5\/3 delivery enhances mda-7\/IL-24 therapy of malignant glioma","volume":"18","author":"Hamed","year":"2010","journal-title":"Mol Ther"},{"key":"10.1124\/mol.114.094375_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/mol.113.086553","article-title":"Histone deacetylase inhibitors interact with melanoma differentiation associated-7\/interleukin-24 to kill primary human glioblastoma cells","volume":"84","author":"Hamed","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.114.094375_bib18","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1101\/gad.1415606","article-title":"Genetics and biology of pancreatic ductal adenocarcinoma","volume":"20","author":"Hezel","year":"2006","journal-title":"Genes Dev"},{"key":"10.1124\/mol.114.094375_bib19","doi-asserted-by":"crossref","first-page":"10201","DOI":"10.1073\/pnas.1300016110","article-title":"Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function","volume":"110","author":"Hocker","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.114.094375_bib20","first-page":"285","article-title":"Use of a sensitive and efficient subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells","volume":"1","author":"Jiang","year":"1993","journal-title":"Mol Cell Differ"},{"key":"10.1124\/mol.114.094375_bib21","first-page":"2477","article-title":"Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression","volume":"11","author":"Jiang","year":"1995","journal-title":"Oncogene"},{"key":"10.1124\/mol.114.094375_bib22","doi-asserted-by":"crossref","first-page":"9160","DOI":"10.1073\/pnas.93.17.9160","article-title":"The melanoma differentiation associated gene mda-7 suppresses cancer cell growth","volume":"93","author":"Jiang","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.114.094375_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10937404.2013.769418","article-title":"Safety evaluation and risk assessment of d-limonene","volume":"16","author":"Kim","year":"2013","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"10.1124\/mol.114.094375_bib24","doi-asserted-by":"crossref","first-page":"8758","DOI":"10.1038\/sj.onc.1206891","article-title":"Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7\/IL-24","volume":"22","author":"Lebedeva","year":"2003","journal-title":"Oncogene"},{"key":"10.1124\/mol.114.094375_bib25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.onc.1208183","article-title":"Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis","volume":"24","author":"Lebedeva","year":"2005","journal-title":"Oncogene"},{"key":"10.1124\/mol.114.094375_bib26","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1158\/0008-5472.CAN-05-3510","article-title":"Molecular target-based therapy of pancreatic cancer","volume":"66","author":"Lebedeva","year":"2006","journal-title":"Cancer Res"},{"key":"10.1124\/mol.114.094375_bib27","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1073\/pnas.0700042104","article-title":"Strategy for reversing resistance to a single anticancer agent in human prostate and pancreatic carcinomas","volume":"104","author":"Lebedeva","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.114.094375_bib28","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1158\/1535-7163.MCT-08-0245","article-title":"Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces pancreatic cancer pathogenesis","volume":"7","author":"Lebedeva","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/mol.114.094375_bib29","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1158\/0008-5472.CAN-08-0072","article-title":"Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene-7\/interleukin-24 and perillyl alcohol","volume":"68","author":"Lebedeva","year":"2008","journal-title":"Cancer Res"},{"key":"10.1124\/mol.114.094375_bib30","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1073\/pnas.1116510109","article-title":"Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity","volume":"109","author":"Maurer","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.114.094375_bib31","first-page":"4208","article-title":"Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines","volume":"5","author":"Pearson","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.114.094375_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/1477-3163.51368","article-title":"d -limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis","volume":"8","author":"Rabi","year":"2009","journal-title":"J Carcinog"},{"key":"10.1124\/mol.114.094375_bib33","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2174\/1566524011313070008","article-title":"Chemoprevention gene therapy (CGT): novel combinatorial approach for preventing and treating pancreatic cancer","volume":"13","author":"Sarkar","year":"2013","journal-title":"Curr Mol Med"},{"key":"10.1124\/mol.114.094375_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1359-6101(02)00074-6","article-title":"MDA-7\/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine","volume":"14","author":"Sauane","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1124\/mol.114.094375_bib35","doi-asserted-by":"crossref","first-page":"9763","DOI":"10.1073\/pnas.0804089105","article-title":"Autocrine regulation of mda-7\/IL-24 mediates cancer-specific apoptosis","volume":"105","author":"Sauane","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.114.094375_bib36","doi-asserted-by":"crossref","first-page":"10332","DOI":"10.1073\/pnas.171315198","article-title":"A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells","volume":"98","author":"Su","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.114.094375_bib37","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1038\/sj.onc.1208911","article-title":"Unique aspects of mda-7\/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7\/IL-24 protein by normal cells","volume":"24","author":"Su","year":"2005","journal-title":"Oncogene"},{"key":"10.1124\/mol.114.094375_bib38","doi-asserted-by":"crossref","first-page":"14400","DOI":"10.1073\/pnas.95.24.14400","article-title":"The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice","volume":"95","author":"Su","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.114.094375_bib39","first-page":"259","article-title":"D-limonene: safety and clinical applications","volume":"12","author":"Sun","year":"2007","journal-title":"Altern Med Rev"},{"key":"10.1124\/mol.114.094375_bib40","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1002\/anie.201201358","article-title":"Discovery of small molecules that bind to K-Ras and inhibit Sos-mediated activation","volume":"51","author":"Sun","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/mol.114.094375_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymthe.2004.09.021","article-title":"Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7\/IL24): biologic outcome in advanced cancer patients","volume":"11","author":"Tong","year":"2005","journal-title":"Mol Ther"},{"key":"10.1124\/mol.114.094375_bib42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24030189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24030189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.114.094375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:02:12Z","timestamp":1739959332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24030189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0026895X24030189"],"URL":"https:\/\/doi.org\/10.1124\/mol.114.094375","relation":{},"ISSN":["0026-895X"],"issn-type":[{"type":"print","value":"0026-895X"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversing Translational Suppression and Induction of Toxicity in Pancreatic Cancer Cells Using a Chemoprevention Gene Therapy Approach","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.114.094375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}